Review your content's performance and reach.
Become your target audience’s go-to resource for today’s hottest topics.
Understand your clients’ strategies and the most pressing issues they are facing.
Keep a step ahead of your key competitors and benchmark against them.
Articles: 1-10 of 1525
USA - September 21 2023 As defense attorneys who represent drug and device companies, we generally cheer when a state-law claim is held preempted by the FDCA. We are…
USA - September 20 2023 Kulkarni v. Generics, 2023 U.S.Dist.LEXIS 160730 (S.D.N.Y. Sept. 8, 2023), is an interesting generic preemption (mostly) dismissal involving an “old”…
USA - September 19 2023 We know this is the Drug and Device Law Blog, but the similarities between food labeling preemption and medical device preemption are just too strong…
USA - September 18 2023 Bexis has been updating the preemption chapter of his treatise on drug/device product liability litigation. He came across several preemption…
USA - September 15 2023 We often marvel at how plaintiffs’ attorneys find new ways to sue businesses, including under RICO. Take for example the ever-increasing number of…
USA - September 14 2023 Sometimes there are decisions that we begin to read with an expectation—perhaps based on a thumbnail from Bexis—that we will have a strong impression…
USA - September 13 2023 South Carolina is a lovely state with mostly lovely weather, though this time of year its appearance on the MAP looks like the country's jutted chin…
USA - September 12 2023 If a court tells you your only non-preempted claim is one based on a theory that your labeling does not comply with the Federal Food, Drug & Cosmetic…
USA - September 11 2023 When we last commented on the Alliance for Hippocratic Medicine v. FDA litigation, back in April, the United States Supreme Court had just stayed…
USA - September 8 2023 As a defense lawyer, one grows accustomed to clear judicial days on which the state court can foresee forever. See Thing v. La Chusa, 48 Cal. 3d 644…